SS-Inclisiran sodium is an innovative therapeutic agent employing small interfering RNA (siRNA) technology for combating hypercholesterolemia. Its mechanism of action involves suppressing hepatic production of proprotein convertase subtilisin/kexin type 9 (PCSK9) messenger RNA, resulting in diminished PCSK9 protein concentration and consequent reduction of LDL cholesterol levels in afflicted individuals.
Chemical Structure:

BOC Sciences is a leading provider of DNA and RNA products and services that meet the needs of researchers and pharmaceutical companies worldwide. Its broad product portfolio includes various types of oligonucleotides, DNA/RNA synthesis feedstocks, RNA interference tools, and advanced drug delivery systems, among others. Designed to promote cutting-edge research and innovative therapeutic solutions, at BOC Sciences you are sure to find the right product for you.